New pill shows promise for Hard-to-Treat cancers
NCT ID NCT05287399
First seen Jan 08, 2026 · Last updated Apr 30, 2026 · Updated 19 times
Summary
This early-stage trial tested a new oral drug called ASC61 in 18 adults with advanced solid tumors that had stopped responding to standard treatments or had no standard options. The goal was to check the drug's safety, find the right dose, and see if it could shrink tumors. ASC61 works by blocking a protein called PD-L1, which helps the immune system attack cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
California Cancer Associates for Research & Excellence (cCARE)
Encinitas, California, 92024, United States
-
California Cancer Associates for Research & Excellence (cCARE)
Fresno, California, 93720, United States
-
California Cancer Associates for Research & Excellence (cCARE)
San Marcos, California, 92069, United States
-
Nebraska Cancer Specialists
Omaha, Nebraska, 68130, United States
Conditions
Explore the condition pages connected to this study.